Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial-Reference-Cited by-同舟云学术

Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial

Published:2021-05 Issue:5 Volume:22 Page:665-677
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Andre Thierry,Amonkar Mayur,Norquist Josephine M,Shiu Kai-Keen,Kim Tae Won,Jensen Benny Vittrup,Jensen Lars Henrik,Punt Cornelis J A,Smith Denis,Garcia-Carbonero Rocio,Sevilla Isabel,De La Fouchardiere Christelle,Rivera Fernando,Elez Elena,Diaz Luis A,Yoshino Takayuki,Van Cutsem Eric,Yang Ping,Farooqui Mohammed,Le Dung T

Funder

Merck

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors;Rawla;Prz Gastroenterol,2019

2. Improving outcomes in patients with CRC: The role of patient reported outcomes-an ESDO report;Van Cutsem;Cancers,2017

3. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016

4. Symptom prevalence in lung and colorectal cancer patients;Walling;J Pain Symptom Manage,2015

5. Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy;Soveri;Acta Oncol,2019

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing changes in the quality of life of the Hainan migratory population with hypertension: A survey of the Chengmai Mangrove Bay community;2024-08-14

2. Immunomodulatory molecules in colorectal cancer liver metastasis;Cancer Letters;2024-08

3. An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer;Clinical Colorectal Cancer;2024-08

4. Clinical Outcomes of Elective Early Discontinuation of Immunotherapy Based on Objective Response in Microsatellite Instability-High Metastatic Colorectal Cancer;Clinical Colorectal Cancer;2024-08

5. Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review;International Journal of Gastrointestinal Intervention;2024-07-31